Drugs / AquADEKs-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01859390 | Jun 2013 → Apr 2015 | cystic fibrosis | University of Colorado, Denver | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AquADEKs-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01859390 ↗ |
| Modality | Other / unclassified | “Antioxidant-enriched multivitamin supplement” NCT01859390 ↗ |
| Route | Oral | “two AquADEKs-2 softgel capsules will be taken orally on a once daily basis” NCT01859390 ↗ |